Tiziana Life Sciences Plc (TILS) - Financial and Strategic SWOT Analysis Review

Tiziana Life Sciences Plc (TILS) - Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH81774FSA
  • |
  • Pages: 55
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Tiziana Life Sciences Plc (TILS) Financial and Strategic SWOT Analysis Review provides you an in depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description A detailed description of the company's operations and business divisions.

Corporate strategy Analyst's summarization of the company's business strategy.

SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history Progression of key events associated with the company.

Major products and services A list of major products, services and brands of the company.

Key competitors A list of key competitors to the company.

Key employees A list of the key executives of the company.

Executive biographies A brief summary of the executives' employment history.

Key operational heads A list of personnel heading key departments/functions.

Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi annual financial statements published by the company for 5 interims history.

Highlights

Tiziana Life Sciences Plc (Tiziana), formerly Alexander David Investments Plc, is a clinical stage biotechnology company that discovers and develops drugs to treat diseases in oncology and immunology. The company's lead product candidate, TZLS 201, intended for the treatment of thymic carcinoma. Its other clinical programmes include TZLS 401, a human engineered anti human CD3 antibody intended for the treatment of autoimmune and inflammatory diseases. The company's preclinical stage candidates include TZLS 501, a fully human anti IL 6R monoclonal antibody targeting the interleukin 6 receptor; and StemPrintER, a multi gene signature assay intended for the treatment of patients with breast cancer. Tiziana is headquartered in London, the UK.

Tiziana Life Sciences Plc Key Recent Developments

Jun 07,2018: Tiziana Life Sciences: Financial Results for the Year Ended 31 December 2017

Apr 04,2018: Tiziana Life Sciences: Appointment of Director

Sep 29,2017: Tiziana Life Sciences: Interim Results for the Six Months Ended 30 June 2017

Jun 12,2017: Tiziana Life Sciences Strengthens Unique Research Focus by Appointing Dr Kunwar Shailubhai as Chief Executive Officer

Jun 12,2017: Tiziana Life Sciences names Kunwar Shailubhai as CEO

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1 About the Company 5

Tiziana Life Sciences Plc Key Facts 5

Tiziana Life Sciences Plc Key Employees 6

Tiziana Life Sciences Plc Key Employee Biographies 7

Tiziana Life Sciences Plc Key Operational Employees 8

Tiziana Life Sciences Plc Major Products and Services 9

Tiziana Life Sciences Plc History 10

Tiziana Life Sciences Plc Locations And Subsidiaries 13

Head Office 13

Other Locations & Subsidiaries 13

Section 2 Company Analysis 14

Company Overview 14

Tiziana Life Sciences Plc Business Description 15

Tiziana Life Sciences Plc Corporate Strategy 16

Tiziana Life Sciences Plc SWOT Analysis 17

SWOT Analysis Overview 17

Tiziana Life Sciences Plc Strengths 17

Tiziana Life Sciences Plc Weaknesses 18

Tiziana Life Sciences Plc Opportunities 19

Tiziana Life Sciences Plc Threats 20

Tiziana Life Sciences Plc Key Competitors 21

Section 3 Company Financial Ratios 22

Financial Ratios Capital Market Ratios 22

Financial Ratios Annual Ratios 23

Performance Chart 25

Financial Performance 25

Financial Ratios Interim Ratios 26

Financial Ratios Ratio Charts 27

Section 4 Company's Lifesciences Financial Deals and Alliances 28

Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29

Tiziana Life Sciences Plc, Recent Deals Summary 30

Section 5 Company's Recent Developments 31

Jun 07, 2018: Tiziana Life Sciences: Financial Results for the Year Ended 31 December 2017 31

Apr 04, 2018: Tiziana Life Sciences: Appointment of Director 38

Sep 29, 2017: Tiziana Life Sciences: Interim Results for the Six Months Ended 30 June 2017 39

Jun 12, 2017: Tiziana Life Sciences Strengthens Unique Research Focus by Appointing Dr Kunwar Shailubhai as Chief Executive Officer 45

May 23, 2017: Tiziana Life Sciences: Financial Results for the Year Ended 31 December 2016 47

Mar 14, 2017: Tiziana Life Sciences appoints new scientific advisory board member 48

Mar 14, 2017: Tiziana Life Sciences Appoints Dr. Arun Sanyal to its Scientific Advisory Board 49

Mar 14, 2017: Tiziana Life Sciences Appoints Dr. Arun Sanyal to its Scientific Advisory Board 50

Section 6 Appendix 51

Methodology 51

Ratio Definitions 51

About GlobalData 55

Contact Us 55

Disclaimer 55

List of Figures

Tiziana Life Sciences Plc, Performance Chart (2013 2017) 25

Tiziana Life Sciences Plc, Ratio Charts 27

Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 29

List of Tables

Tiziana Life Sciences Plc, Key Facts 5

Tiziana Life Sciences Plc, Key Employees 6

Tiziana Life Sciences Plc, Key Employee Biographies 7

Tiziana Life Sciences Plc, Key Operational Employees 8

Tiziana Life Sciences Plc, Major Products and Services 9

Tiziana Life Sciences Plc, History 10

Tiziana Life Sciences Plc, Other Locations 13

Tiziana Life Sciences Plc, Subsidiaries 13

Tiziana Life Sciences Plc, Key Competitors 21

Tiziana Life Sciences Plc, Ratios based on current share price 22

Tiziana Life Sciences Plc, Annual Ratios 23

Tiziana Life Sciences Plc, Annual Ratios (Cont...1) 24

Tiziana Life Sciences Plc, Interim Ratios 26

Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29

Tiziana Life Sciences Plc, Recent Deals Summary 30

Currency Codes 51

Capital Market Ratios 51

Equity Ratios 52

Profitability Ratios 52

Cost Ratios 53

Liquidity Ratios 53

Leverage Ratios 54

Efficiency Ratios 54

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Tragara Pharmaceuticals Inc

Juno Therapeutics Inc

Iovance Biotherapeutics Inc

BioNTech AG

Tiziana Life Sciences Plc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license
Single User License
USD 125 INR 8923
Site License
USD 250 INR 17845
Corporate User License
USD 375 INR 26768

NEWSLETTER BY CATEGORY




Testimonials

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com